Literature DB >> 6209579

Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation.

D J Charron, V Lotteau, P Turmel.   

Abstract

In the mouse there are hybrid determinants for the immune region (Ir) of the genome which contribute to the diversity of class II (Ia) antigens of the major histocompatibility complex (MHC) and provide a molecular basis for Ir gene complementation. In man, two prominent families of Ia molecule, HLA-DR and HLA-DC (or DS), have been identified which are respectively homologous to the murine I-E (E alpha, E beta) and I-A (A alpha, A beta) antigens. Whereas DR antigens consist of a constant alpha-chain and an extremely polymorphic beta-chain, both the alpha and beta subunits of DC antigens are structurally variable when different alleles are compared. The marked differences in the structure of the alpha- and beta-chains of HLA-DC molecules result in electrophoretic variants which allow the haplotype of origin of each subunit to be identified by two-dimensional gel electrophoresis. We report here that gene trans-complementation occurs in cells heterozygous for the HLA-D region, resulting in the expression of hybrid HLA-DC molecules in addition to the parental forms. Generation of new HLA-D region hybrid molecules contributes to the qualitative diversity of human MHC class II antigens and has important functional implications in immune regulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209579     DOI: 10.1038/312157a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Authors:  Willemijn Vader; Dariusz Stepniak; Yvonne Kooy; Luisa Mearin; Allan Thompson; Jon J van Rood; Liesbeth Spaenij; Frits Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

Review 2.  HLA 1990.

Authors:  W R Mayr
Journal:  Blut       Date:  1990-10

Review 3.  Interisotypic alpha- and beta-chain assembly as a source of HLA class-II diversity.

Authors:  D J Charron; P Hermans; V Lotteau; B Merlu; F Amesland; P Turmel; L Tevton
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 4.  The major histocompatibility complex of primates.

Authors:  E R Heise; D J Cook; B S Schepart; C H Manning; M R McMahan; M Chedid; C A Keever
Journal:  Genetica       Date:  1987-08-31       Impact factor: 1.082

5.  Structural and functional studies of trans-encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) protein molecule.

Authors:  Stig Tollefsen; Kinya Hotta; Xi Chen; Bjørg Simonsen; Kunchithapadam Swaminathan; Irimpan I Mathews; Ludvig M Sollid; Chu-Young Kim
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

6.  A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.

Authors:  I Khalil; L d'Auriol; M Gobet; L Morin; V Lepage; I Deschamps; M S Park; L Degos; F Galibert; J Hors
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 7.  Structural variation among major histocompatibility complex class-II genes which predispose to autoimmunity.

Authors:  G T Nepom
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

8.  A novel HLA class II molecule.

Authors:  N Fernandez; M O Labeta; H Festenstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. III. Family segregation analyses.

Authors:  S Rosen-Bronson; A H Johnson; R J Hartzman; D D Eckels
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.

Authors:  Nathali Kaushansky; Miriam Eisenstein; Sigalit Boura-Halfon; Bjarke Endel Hansen; Claus Henrik Nielsen; Ron Milo; Gabriel Zeilig; Hans Lassmann; Daniel M Altmann; Avraham Ben-Nun
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.